Atteintes rénales au cours du déficit en cobalamine C - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Néphrologie & Thérapeutique Year : 2019

Atteintes rénales au cours du déficit en cobalamine C

[Kidney disease in cobalamin C deficiency].


Cobalamin C deficiency (cblC) is the most common inborn error of vitamin B12 metabolism. This autosomal recessive disease is due to mutations in MMACHC gene, encoding a cyanocobalamin decyanase. It leads to hyperhomocysteinemia associated with hypomethioninemia and methylmalonic aciduria. Two distinct phenotypes have been described : early-onset forms occur before the age of one year and are characterized by a severe multisystem disease associating failure to thrive to neurological and ophthalmological manifestations. They are opposed to late-onset forms, less severe and heterogeneous. CblC deficiency-associated kidney lesions remain poorly defined. Thirty-eight cases have been described. Age at initial presentation varied from a few days to 28 years. Most of the patients presented renal thrombotic microangiopathy (TMA) associated with acute renal failure, and 21 patients presented typical lesions of renal thrombotic microangiopathy on kidney biopsy. Prognosis was poor, leading to death in the absence of treatment, and related to the severity of renal lesions in the early-onset forms. Late-onset disease had better prognosis and most of patients were weaned off dialysis after treatment initiation. We suggest that all the patients with renal TMA be screened for cobalamin metabolism disorder, regardless of age and even in the absence of neurological symptoms, to rapidly initiate the appropriate treatment.
Fichier principal
Vignette du fichier
S1769725519301208.pdf (2.59 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-02444989 , version 1 (25-10-2021)


Attribution - NonCommercial



Mathilde Lemoine, Steven Grangé, Dominique Guerrot. Atteintes rénales au cours du déficit en cobalamine C. Néphrologie & Thérapeutique, 2019, 15 (4), pp.201-214. ⟨10.1016/j.nephro.2019.03.011⟩. ⟨inserm-02444989⟩
41 View
319 Download



Gmail Facebook X LinkedIn More